Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder-Reference-Cited by-同舟云学术

Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder

Published:2016-09 Issue:5 Volume:31 Page:275-286
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:International Clinical Psychopharmacology

Author:

Woo Young Sup,Bahk Won-Myong,Park Young-Min,Chung Sangkeun,Yoon Bo-Hyun,Won Seunghee,Lee Jeong Goo,Lee Hwang-Bin,Kim Won,Jeong Jong-Hyun,Lee Kwanghun,Kim Moon-Doo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference75 articles.

1. Factors associated with treatment nonadherence among US bipolar disorder patients

2. A Non-randomized, Open Study with Aripiprazole and Ziprasidone for the Treatment of Aggressive Behavior in Youth in a Community Clinic

3. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study

4. Self-reported data from patients with bipolar disorder: Frequency of brief depression

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis;Translational Psychiatry;2022-07-05

2. Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis;Frontiers in Endocrinology;2021-07-28

3. Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis;Schizophrenia Bulletin;2021-02-06

4. The Impact of Subsyndromal Bipolar Symptoms on Patient’s Functionality and Quality of Life;Frontiers in Psychiatry;2020-06-12

5. Obesity and the pharmacotherapy of bipolar disorder;Pharmacotherapy in Psychiatry and Neurology;2020